PReS13-SPK-1576: Unmeet needs in JIA treatment

por Ruperto, N
Publicado 2013

OR7-004 – Validation of AIDAI score

por Piram, M, Koné-Paut, I, Gattorno, M, Ruperto, N
Publicado 2013

A meta-analysis to estimate the “real” placebo effect in juvenile idiopathic arthritis (JIA) trials

por Demirkaya, E, Ruperto, N, Galasso, R, Ravelli, A, Palmisani, E, Martini, A, Pistorio, A
Publicado 2011

Investigating which variables from the core outcome variables in juvenile idiopathic arthritis (JIA) are the best predictors of classification as a responder to treatment with meth...

por Hirani, SP, Kassoumeri, L, Mulligan, K, Ruperto, N, Woo, P, Wedderburn, LR, Newman, SP
Publicado 2008

The Eurofever Project: towards the longitudinal stage

por Federici, S, Frenkel, J, Ozen, S, Finetti, M, Garibotto, F, Lachmann, H, Martini, A, Ruperto, N
Publicado 2015

PReS-FINAL-2070: Efficacy of biologic treatments in juvenile idiopathic arthritis with a polyarticular course: an indirect comparison

por Sawyer, L, Diamantopoulos, A, Brunner, HI, De Benedetti, F, Ruperto, N, Dejonckheere, F, Keane, C
Publicado 2013

Investigating the use of a limited core outcome variable set for the classification of response following methotrexate treatment in juvenile idiopathic arthritis (JIA)

por Hirani, SP, Kassoumeri, L, Etheridge, A, Mulligan, K, Ruperto, N, Woo, P, Wedderburn, L, Newman, SP
Publicado 2008

PReS-FINAL-2169: Exposure-response modeling of canakinumab in the avoidance of flares in children with systemic juvenile idiopathic arthritis

por Xiong, Y, Wang, W, Ebling, W, Sun, H, Luttringer, O, Abrams, K, Ruperto, N, Brunner, H
Publicado 2013

How experts on autoinflammatory diseases classify inherited periodic fevers: preliminary results of the Eurofever Delphi Survey

por Federici, S, Vanoni, F, Ozen, S, Frenkel, J, Lachmann, H, Martini, A, Ruperto, N, Hofer, M, Gattorno, M
Publicado 2015

How experts on Autoinflammatory diseases classify Periodic Fever, Aphthous stomatitis, Pharyngitis and Cervical Adenitis (PFAPA): preliminary results of the Eurofever Delphi survey

por Vanoni, F, Federici, S, Ozen, S, Frenkel, J, Lachmann, H, Martini, A, Ruperto, N, Gattorno, M, Hofer, M
Publicado 2015

PReS-FINAL-2132: Defining criteria for high disease activity in juvenile idiopathic arthritis: definition and validation of juvenile arthritis disease activity score cutoffs

por Consolaro, A, Verazza, S, Gallo, MC, Bracciolini, G, Negro, G, Frisina, A, Ruperto, N, Martini, A, Ravelli, A
Publicado 2013

Comparison of the accuracy of different definitions of clinical remission (CR) and minimal disease activity (MDA) in juvenile idiopathic arthritis (JIA)

por Davì, S, Consolaro, A, Ferrari, C, Federici, S, Vitale, R, Filocamo, G, Loy, A, Ruperto, N, Martini, A, Ravelli, A
Publicado 2008

PReS-FINAL-2159: Tocilizumab (TCZ) dosing in juvenile idiopathic arthritis (JIA): optimising for different JIA type and body weight patients

por Lu, P, Hsu, J, Keane, C, Fettner, S, Wang, J, Ruperto, N, Harari, O, Brunner, HI, De Benedetti, F
Publicado 2013

PW02-005 - A web registry of genotype-phenotype correlation

por Doglio, M, Papa, R, Caorsi, R, Federici, S, Finetti, M, Naselli, A, Ruperto, N, Martini, A, Ceccherini, I, Gattorno, M
Publicado 2013

PReS-FINAL-2345: Frequency of radiographic damage and progression in individual joints in children with juvenile idiopathic arthritis

por Giancane, G, Pederzoli, S, Norambuena, X, Ioseliani, M, Sato, J, Gallo, MC, Negro, G, Ruperto, N, Martini, A, Ravelli, A
Publicado 2013

A new approach to defining inactive disease, minimal disease activity and parent- and child-acceptable symptom state in juvenile idiopathic arthritis

por Consolaro, A, Filocamo, G, Bertamino, M, Palmisani, E, Bracciolini, G, Suffia, C, Muratore, V, Ruperto, N, Martini, A, Ravelli, A
Publicado 2011

Development and initial validation of the parent acceptable symptom state in juvenile idiopathic arthritis (JIA)

por Filocamo, G, Schiappapietra, B, Manzoni, S Magni, Lanni, S, Solari, N, Viola, S, Pistorio, A, Ruperto, N, Tani, D, Martini, A, Ravelli, A
Publicado 2008

Evaluation of the power of six clustering features in identifying a homogeneous disease subset in juvenile idiopathic arthritis (JIA)

por Magnani, A, Oliveira, S, Castell, E, Arguedas, O, Ullmann, N, Pederzoli, S, Manzoni, S Magni, Pistorio, A, Ruperto, N, Martini, A, Ravelli, A
Publicado 2008

PReS-FINAL-2129: Whole-body versus localized magnetic resonance imaging in the assessment of juvenile dermatomyositis

por Madeo, A, Damasio, MB, Dellepiane, M, Providenti, A, Beleva, D, Buoncompagni, A, Beltramo, A, Ruperto, N, Martini, A, Malattia, C
Publicado 2013

Use of the JADAS criteria to assess efficacy of canakinumab in patients with SJIA – an analysis of 12-week pooled data

por Ravelli, A, Brunner, HI, Ruperto, N, Quartier, P, Consolaro, A, Wulffraat, N, Lheritier, K, Gaillez, C, Martini, A, Lovell, DJ
Publicado 2014